Page 2 - Stock Market Listing

KSH International to list on Dec 23: Here's what latest GMP hints at

KSH International IPO witnessed underwhelming response from investors, getting oversubscribed only 83 per cent overall

ICICI Pru AMC makes solid debut, analysts upbeat on long-term; here's why

Domestic brokerages Equirus Securities and PL Capital have initiated coverage on ICICI Prudential Asset Management Company

ICICI Pru AMC makes solid D-St debut; lists at 20% premium on bourses

ICICI Prudential AMC shares listed at ₹2,600 on the NSE, a premium of ₹435 or 26 per cent from the issue price of ₹2,165

Park Medi World makes muted debut, lists at 4% discount; miss GMP estimates

Park Medi World shares opened at ₹158.80 on the NSE, a discount of ₹3.2 or 2 per cent from the issue price of ₹162

Corona Remedies makes bumper D-St debut; lists at 38% premium on bourses

Corona Remedies shares opened at ₹1,470 on the NSE, a premium of ₹408 or 38 per cent from the issue price of ₹1,062

Corona Remedies IPO to list on Dec 15; here's what GMP hints for D-St debut

Corona Remedies IPO received an overwhelming investor interest, achieving an overall oversubscription of 137 times, driven largely by strong participation from QIBs

Aequs lists at 13% premium; analysts flag upside with caution; find out why

Analysts suggest investors to hold for long term, citing the company's strong positioning as one of India's most advanced aerospace precision-manufacturing platforms

Meesho lists at 46% premium; analysts upbeat on long-term view; here's why

Choice Equity Broking has initiated coverage on Meesho with a 'Buy' rating, citing the company's structural competitive Moats, strong monetisation runway, and accelerating path to profitability

Vidya Wires makes flat D-street debut at ₹52; misses GMP estimates

Ahead of debut, Vidya Wires shares were quoting at ₹55.5 in the grey market, reflecting a premium of ₹3.5 or 6.7 per cent over the issue price

Aequs IPO listing on December 10: Here's what latest GMP indicates

Ahead of its listing, the unlisted shares of Aequs were trading at around ₹152 per share in the grey market, indicating a premium of ₹28 or 22.6 per cent

Meesho IPO to make D-St debut on Dec 10: Here's what latest GMP hints at

Overall subscription for Meesho IPO was strong at 79.03 times, with total bids at 21.96 billion shares against the 277.93 million shares on offer

Meesho IPO subscribed 2.4 times on day one; retail book nearly four times

Meesho's IPO was subscribed 2.4 times on the first day, driven by strong retail demand, after it raised Rs 2,440 crore from anchors and set a price band of Rs 105-111 per share

Sudeep Pharma makes positive D-St debut; lists at 23% premium on bourses

Sudeep Pharma shares opened at ₹733.95, a premium of ₹140.95 or 23.8 per cent

Sudeep Pharma IPO to list on Nov 28: Here's what latest GMP hints at

Sudeep Pharma IPO witnessed robust investor interest, getting oversubscribed 93.72 times overall, driven largely by strong participation from QIBs

Excelsoft Tech makes positive D-St debut; lists at 12% premium on bourses

Excelsoft Technologies shares listed at ₹135 per share on the NSE, opening with a 12.5 per cent premium over the issue price of ₹120

Excelsoft Tech IPO to list on Nov 26; here's what GMP hints for D-St debut

Excelsoft's unlisted shares were trading at around ₹125.5 per share in the grey market, indicating a premium of ₹5.5 or 4.6 per cent

Tenneco Clean Air stock lists at 27% premium; should you buy, sell or hold?

Tenneco Clean Air stock listed at ₹505 on the NSE, opening with a 27 per cent premium over the issue price of ₹397 per share

PhysicsWallah makes solid debut; analysts split on outlook; hold or sell?

PhysicsWallah stock made a solid debut on Dalal Street, listing at ₹145 on the NSE, a 33 per cent premium compared to the issue price of ₹109

Bumper debut! PhysicsWallah lists at 33% premium, beats GMP forecasts

PhysicsWallah share price: On the BSE, the PhysicsWallah shares opened at ₹143.1, a premium of 31.2 per cent

Lenskart lists flat after volatile debut; valuation debate lingers

Eyewear retailer Lenskart's stock fluctuated sharply on listing day, ending nearly unchanged as investors weighed its steep valuation and long-term growth potential